Clinical Trial Update: Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) [NA]

View source ↗

Summary

The IDE2 trial evaluating Insulet's artificial pancreas for meal performance and moderate exercise in Type 1 diabetes has completed. The update notes the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulet Artificial Pancreas (IDE2)

Snippet

Sponsor: Insulet Corporation | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED